BIOMAT Database Logo BIOMAT Database Logo

[Chloroquine and hydroxychloroquine dosage in juvenile rheumatoid arthritis]. 1974

A L Laaksonen, and V Koskiahde, and K Juva

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D003318 Corneal Opacity Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque. Leukoma,Corneal Opacities,Leukomas,Opacities, Corneal,Opacity, Corneal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006886 Hydroxychloroquine A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) Hydroxychlorochin,Oxychlorochin,Oxychloroquine,Hydroxychloroquine Sulfate,Hydroxychloroquine Sulfate (1:1) Salt,Plaquenil

Related Publications

A L Laaksonen, and V Koskiahde, and K Juva
Chloroquine and hydroxychloroquine therapy in rheumatoid arthritis.
February 1962, Arthritis and rheumatism,
A L Laaksonen, and V Koskiahde, and K Juva
[Treatment of juvenile rheumatoid arthritis with chloroquine phosphate and hydroxychloroquine sulphate. Dosage of syrup and tablets with determinations of serum concentrations].
March 1971, Nordisk medicin,
A L Laaksonen, and V Koskiahde, and K Juva
[Dosage of salicylates in juvenile rheumatoid arthritis].
June 1975, Kinderarztliche Praxis,
A L Laaksonen, and V Koskiahde, and K Juva
Hydroxychloroquine in rheumatoid arthritis.
November 1984, Arthritis and rheumatism,
A L Laaksonen, and V Koskiahde, and K Juva
Chloroquine-induced vitiligo in a patient with juvenile onset rheumatoid arthritis.
November 1992, British journal of rheumatology,
A L Laaksonen, and V Koskiahde, and K Juva
Chloroquine in rheumatoid arthritis.
August 1959, Annals of physical medicine,
A L Laaksonen, and V Koskiahde, and K Juva
[Chloroquine in rheumatoid arthritis].
February 1958, La Prensa medica mexicana,
A L Laaksonen, and V Koskiahde, and K Juva
[Chloroquine in rheumatoid arthritis].
May 1958, Nordisk medicin,
A L Laaksonen, and V Koskiahde, and K Juva
Amodiaquine and hydroxychloroquine in rheumatoid arthritis.
November 1959, Lancet (London, England),
A L Laaksonen, and V Koskiahde, and K Juva
[Rheumatoid arthritis and juvenile rheumatoid arthritis].
January 1996, Ryoikibetsu shokogun shirizu,
Copied contents to your clipboard!